Kevin Ess
Concepts (336)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberous Sclerosis | 22 | 2025 | 55 | 4.750 |
Why?
| | Tumor Suppressor Proteins | 13 | 2023 | 325 | 3.160 |
Why?
| | Induced Pluripotent Stem Cells | 15 | 2025 | 265 | 1.780 |
Why?
| | TOR Serine-Threonine Kinases | 10 | 2023 | 428 | 1.450 |
Why?
| | Cellular Reprogramming | 2 | 2025 | 98 | 1.410 |
Why?
| | Sirolimus | 7 | 2024 | 276 | 1.040 |
Why?
| | Astrocytoma | 3 | 2021 | 130 | 1.010 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 3 | 2025 | 55 | 1.000 |
Why?
| | Neural Stem Cells | 7 | 2019 | 159 | 0.950 |
Why?
| | Tumor Suppressor Protein p53 | 5 | 2017 | 526 | 0.950 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 9 | 2025 | 131 | 0.910 |
Why?
| | Multiprotein Complexes | 4 | 2013 | 171 | 0.880 |
Why?
| | Cell Differentiation | 11 | 2025 | 1999 | 0.860 |
Why?
| | Neurons | 8 | 2020 | 1615 | 0.860 |
Why?
| | Hemiplegia | 3 | 2025 | 21 | 0.850 |
Why?
| | Brain | 9 | 2024 | 2852 | 0.830 |
Why?
| | Epilepsy | 5 | 2021 | 347 | 0.800 |
Why?
| | Signal Transduction | 14 | 2023 | 5148 | 0.790 |
Why?
| | Fibroblasts | 2 | 2025 | 1017 | 0.740 |
Why?
| | Zebrafish | 6 | 2023 | 504 | 0.740 |
Why?
| | Epilepsy, Generalized | 1 | 2021 | 19 | 0.700 |
Why?
| | Mosaicism | 1 | 2021 | 74 | 0.680 |
Why?
| | Skin | 1 | 2025 | 764 | 0.670 |
Why?
| | White Matter | 4 | 2017 | 147 | 0.650 |
Why?
| | Loss of Heterozygosity | 1 | 2017 | 51 | 0.550 |
Why?
| | Neurogenesis | 3 | 2017 | 153 | 0.520 |
Why?
| | Autistic Disorder | 1 | 2019 | 210 | 0.500 |
Why?
| | Heterozygote | 2 | 2017 | 308 | 0.500 |
Why?
| | Brain Neoplasms | 2 | 2021 | 1275 | 0.480 |
Why?
| | Autism Spectrum Disorder | 1 | 2021 | 418 | 0.470 |
Why?
| | Diffusion Tensor Imaging | 2 | 2015 | 75 | 0.470 |
Why?
| | Gene Deletion | 2 | 2013 | 388 | 0.430 |
Why?
| | Everolimus | 4 | 2025 | 110 | 0.430 |
Why?
| | Mutation | 9 | 2025 | 3999 | 0.420 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2013 | 2 | 0.410 |
Why?
| | Electron-Transferring Flavoproteins | 1 | 2013 | 4 | 0.410 |
Why?
| | Cell Culture Techniques | 3 | 2025 | 368 | 0.410 |
Why?
| | Zebrafish Proteins | 2 | 2013 | 292 | 0.400 |
Why?
| | Gene Knock-In Techniques | 1 | 2013 | 59 | 0.390 |
Why?
| | Carrier Proteins | 4 | 2015 | 746 | 0.390 |
Why?
| | Mice, Knockout | 12 | 2019 | 3064 | 0.390 |
Why?
| | Astrocytes | 5 | 2024 | 216 | 0.380 |
Why?
| | Regenerative Medicine | 1 | 2013 | 52 | 0.380 |
Why?
| | Kidney Tubules, Distal | 1 | 2012 | 5 | 0.380 |
Why?
| | Mitochondrial Diseases | 1 | 2013 | 94 | 0.380 |
Why?
| | Neuroglia | 2 | 2011 | 173 | 0.370 |
Why?
| | Gene Silencing | 1 | 2013 | 197 | 0.370 |
Why?
| | Disease Models, Animal | 13 | 2017 | 4407 | 0.370 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2012 | 47 | 0.360 |
Why?
| | Immunosuppressive Agents | 2 | 2019 | 854 | 0.360 |
Why?
| | Animals | 35 | 2025 | 37579 | 0.360 |
Why?
| | Seizures | 4 | 2021 | 439 | 0.360 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 4 | 2017 | 28 | 0.360 |
Why?
| | Stem Cell Transplantation | 1 | 2013 | 187 | 0.360 |
Why?
| | Corpus Callosum | 1 | 2012 | 69 | 0.360 |
Why?
| | Cells, Cultured | 8 | 2025 | 4199 | 0.350 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2015 | 466 | 0.340 |
Why?
| | Cilia | 1 | 2012 | 172 | 0.340 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 332 | 0.340 |
Why?
| | Mice | 24 | 2025 | 18057 | 0.340 |
Why?
| | Blood-Brain Barrier | 2 | 2024 | 145 | 0.330 |
Why?
| | Myelin Sheath | 3 | 2017 | 164 | 0.330 |
Why?
| | Interneurons | 1 | 2011 | 124 | 0.330 |
Why?
| | Codon, Nonsense | 1 | 2010 | 43 | 0.330 |
Why?
| | Nervous System Diseases | 1 | 2013 | 277 | 0.320 |
Why?
| | Humans | 48 | 2025 | 140898 | 0.310 |
Why?
| | Trans-Activators | 4 | 2012 | 394 | 0.310 |
Why?
| | Cerebral Cortex | 4 | 2020 | 457 | 0.300 |
Why?
| | Mutant Proteins | 2 | 2023 | 102 | 0.280 |
Why?
| | Alleles | 3 | 2017 | 883 | 0.270 |
Why?
| | Neurobiology | 1 | 2006 | 14 | 0.240 |
Why?
| | Carcinogenesis | 2 | 2019 | 215 | 0.230 |
Why?
| | Child | 12 | 2025 | 22313 | 0.230 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 3 | 2017 | 62 | 0.230 |
Why?
| | Huntington Disease | 2 | 2016 | 64 | 0.220 |
Why?
| | Electroencephalography | 2 | 2021 | 518 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 3 | 1999 | 624 | 0.210 |
Why?
| | Proteins | 4 | 2015 | 1013 | 0.200 |
Why?
| | Transcription Factors | 4 | 2012 | 1703 | 0.190 |
Why?
| | Arrhythmias, Cardiac | 1 | 2025 | 337 | 0.190 |
Why?
| | Biopsy | 1 | 2025 | 1069 | 0.190 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2014 | 175 | 0.180 |
Why?
| | Fatty Acids | 1 | 2025 | 448 | 0.180 |
Why?
| | Embryonic and Fetal Development | 2 | 1999 | 93 | 0.180 |
Why?
| | Female | 17 | 2025 | 75540 | 0.180 |
Why?
| | Male | 15 | 2025 | 69893 | 0.170 |
Why?
| | Oncogenes | 2 | 1999 | 118 | 0.170 |
Why?
| | Thymus Gland | 3 | 1999 | 317 | 0.170 |
Why?
| | Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 3 | 0.170 |
Why?
| | Mitochondria | 4 | 2015 | 974 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1761 | 0.160 |
Why?
| | GTPase-Activating Proteins | 1 | 2020 | 85 | 0.160 |
Why?
| | DNA Methylation | 1 | 2025 | 640 | 0.160 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 21 | 0.160 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2023 | 340 | 0.160 |
Why?
| | Endothelial Cells | 3 | 2025 | 813 | 0.160 |
Why?
| | Immunization | 1 | 2021 | 405 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 873 | 0.150 |
Why?
| | Lateral Ventricles | 1 | 2019 | 32 | 0.150 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 73 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2020 | 105 | 0.140 |
Why?
| | Aquaporin 4 | 1 | 2019 | 100 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 340 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1104 | 0.140 |
Why?
| | Wnt Signaling Pathway | 2 | 2023 | 202 | 0.140 |
Why?
| | Manganese | 2 | 2014 | 57 | 0.140 |
Why?
| | Genes, p53 | 1 | 2017 | 68 | 0.140 |
Why?
| | Membrane Potentials | 1 | 2018 | 284 | 0.130 |
Why?
| | Parkinson Disease | 2 | 2014 | 566 | 0.130 |
Why?
| | Fibrosis | 1 | 2019 | 542 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1536 | 0.120 |
Why?
| | Phenotype | 3 | 2020 | 3172 | 0.120 |
Why?
| | Demyelinating Diseases | 1 | 2016 | 84 | 0.120 |
Why?
| | Child, Preschool | 7 | 2025 | 11462 | 0.120 |
Why?
| | Myocytes, Cardiac | 2 | 2023 | 536 | 0.120 |
Why?
| | Central Nervous System | 1 | 2017 | 264 | 0.120 |
Why?
| | Genomic Instability | 1 | 2016 | 57 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 624 | 0.120 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 331 | 0.110 |
Why?
| | Infant | 6 | 2018 | 9790 | 0.110 |
Why?
| | Polyesters | 1 | 2015 | 78 | 0.110 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 70 | 0.110 |
Why?
| | Cell Line | 6 | 2015 | 2879 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 279 | 0.110 |
Why?
| | Cadmium | 1 | 2014 | 68 | 0.110 |
Why?
| | Flow Cytometry | 2 | 2024 | 1195 | 0.110 |
Why?
| | Chromatin | 2 | 2015 | 533 | 0.110 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 858 | 0.110 |
Why?
| | Enhancer Elements, Genetic | 1 | 1995 | 188 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 1995 | 174 | 0.110 |
Why?
| | Copper | 1 | 2014 | 115 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2020 | 2822 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 3724 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2015 | 163 | 0.100 |
Why?
| | Checklist | 1 | 2014 | 105 | 0.100 |
Why?
| | Glutamic Acid | 2 | 2007 | 256 | 0.100 |
Why?
| | Brain Diseases | 1 | 2014 | 149 | 0.100 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 80 | 0.100 |
Why?
| | Founder Effect | 1 | 2013 | 11 | 0.100 |
Why?
| | Neoplasm Invasiveness | 1 | 1995 | 508 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2016 | 580 | 0.100 |
Why?
| | Corpus Striatum | 1 | 2014 | 174 | 0.100 |
Why?
| | Manganese Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
| | Abdominal Neoplasms | 1 | 2013 | 47 | 0.100 |
Why?
| | Parkinson Disease, Secondary | 1 | 2012 | 8 | 0.100 |
Why?
| | Stem Cells | 3 | 2023 | 603 | 0.100 |
Why?
| | Homozygote | 1 | 2013 | 201 | 0.100 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 59 | 0.090 |
Why?
| | Adolescent | 7 | 2025 | 22027 | 0.090 |
Why?
| | Paired Box Transcription Factors | 1 | 2012 | 43 | 0.090 |
Why?
| | Genetic Testing | 1 | 2015 | 463 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 263 | 0.090 |
Why?
| | Chlorides | 1 | 2012 | 138 | 0.090 |
Why?
| | Exons | 1 | 2013 | 352 | 0.090 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 386 | 0.090 |
Why?
| | Blotting, Western | 2 | 2012 | 1231 | 0.090 |
Why?
| | Eye Proteins | 1 | 2012 | 92 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 186 | 0.090 |
Why?
| | Blood Vessels | 1 | 2013 | 180 | 0.090 |
Why?
| | SOXB1 Transcription Factors | 1 | 2012 | 65 | 0.090 |
Why?
| | Glioblastoma | 1 | 1995 | 334 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2013 | 2176 | 0.090 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2012 | 139 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 295 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 187 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1220 | 0.080 |
Why?
| | Quinolines | 1 | 2012 | 170 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 442 | 0.080 |
Why?
| | Cell Lineage | 2 | 2019 | 351 | 0.080 |
Why?
| | Cell Size | 1 | 2010 | 89 | 0.080 |
Why?
| | Liver | 3 | 2015 | 1815 | 0.080 |
Why?
| | Environmental Pollutants | 1 | 2012 | 158 | 0.080 |
Why?
| | Lung | 1 | 2023 | 4127 | 0.080 |
Why?
| | Autophagy | 1 | 2013 | 284 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 550 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2015 | 639 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 418 | 0.080 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 169 | 0.080 |
Why?
| | Genetic Markers | 2 | 2005 | 342 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2497 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 195 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 856 | 0.080 |
Why?
| | Cell Death | 1 | 2011 | 387 | 0.080 |
Why?
| | Biomedical Research | 1 | 2016 | 680 | 0.080 |
Why?
| | Hepatocytes | 1 | 2010 | 211 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-myb | 3 | 1999 | 10 | 0.080 |
Why?
| | Spinal Cord Injuries | 1 | 2013 | 231 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2604 | 0.080 |
Why?
| | Behavior, Animal | 1 | 2012 | 515 | 0.070 |
Why?
| | Cell Cycle Proteins | 1 | 2013 | 632 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 428 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1052 | 0.070 |
Why?
| | Pyrazoles | 1 | 2012 | 480 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 408 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 512 | 0.070 |
Why?
| | Aging | 2 | 2023 | 1917 | 0.070 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2007 | 112 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1726 | 0.070 |
Why?
| | Adult | 7 | 2021 | 39134 | 0.060 |
Why?
| | Protein Biosynthesis | 2 | 2013 | 444 | 0.060 |
Why?
| | DNA | 2 | 2012 | 1438 | 0.060 |
Why?
| | Karyotyping | 2 | 2016 | 104 | 0.060 |
Why?
| | Mental Disorders | 1 | 2014 | 1123 | 0.060 |
Why?
| | Sleep | 1 | 2012 | 879 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2010 | 1031 | 0.060 |
Why?
| | Anxiety | 1 | 2012 | 1076 | 0.060 |
Why?
| | Synaptic Transmission | 1 | 2007 | 293 | 0.060 |
Why?
| | Neuronal Plasticity | 1 | 2007 | 303 | 0.050 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 225 | 0.050 |
Why?
| | Death, Sudden, Cardiac | 1 | 2025 | 191 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2014 | 74 | 0.050 |
Why?
| | Mice, Nude | 2 | 2015 | 689 | 0.050 |
Why?
| | Centrosome | 1 | 2023 | 71 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1940 | 0.050 |
Why?
| | DNA Damage | 2 | 2016 | 429 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2917 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 674 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2025 | 3578 | 0.050 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2002 | 27 | 0.050 |
Why?
| | Binding Sites | 2 | 2015 | 1315 | 0.050 |
Why?
| | Electrocardiography | 1 | 2025 | 617 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2368 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 605 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 138 | 0.040 |
Why?
| | Drug Approval | 1 | 2021 | 87 | 0.040 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 80 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 699 | 0.040 |
Why?
| | Malformations of Cortical Development | 1 | 2020 | 13 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2020 | 55 | 0.040 |
Why?
| | Stroke Volume | 1 | 2023 | 590 | 0.040 |
Why?
| | Genetic Variation | 1 | 2025 | 994 | 0.040 |
Why?
| | Advisory Committees | 1 | 2021 | 214 | 0.040 |
Why?
| | Seizures, Febrile | 1 | 2019 | 22 | 0.040 |
Why?
| | Patient Advocacy | 1 | 2020 | 74 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2023 | 515 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 32 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1129 | 0.040 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Odontogenesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Digestive System | 1 | 1999 | 28 | 0.040 |
Why?
| | Culture Media | 1 | 2019 | 163 | 0.040 |
Why?
| | Hair Follicle | 1 | 1999 | 48 | 0.040 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 128 | 0.040 |
Why?
| | Adenosine Deaminase | 2 | 1996 | 40 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 203 | 0.040 |
Why?
| | Machine Learning | 1 | 2024 | 554 | 0.040 |
Why?
| | Thyroid Gland | 1 | 1999 | 91 | 0.040 |
Why?
| | In Situ Hybridization | 1 | 1999 | 319 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1822 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2019 | 128 | 0.030 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2018 | 47 | 0.030 |
Why?
| | Mitosis | 1 | 1999 | 197 | 0.030 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2017 | 20 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2018 | 244 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2019 | 352 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3487 | 0.030 |
Why?
| | Trachea | 1 | 1999 | 255 | 0.030 |
Why?
| | Strategic Planning | 1 | 2016 | 3 | 0.030 |
Why?
| | Zinostatin | 1 | 2016 | 1 | 0.030 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2016 | 17 | 0.030 |
Why?
| | Myosin Light Chains | 1 | 2015 | 28 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 2015 | 13 | 0.030 |
Why?
| | Fluorescence Polarization | 1 | 2015 | 26 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 121 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1995 | 48 | 0.030 |
Why?
| | Genetic Complementation Test | 1 | 1995 | 66 | 0.030 |
Why?
| | Two-Hybrid System Techniques | 1 | 2015 | 57 | 0.030 |
Why?
| | Base Sequence | 2 | 1996 | 2169 | 0.030 |
Why?
| | Anisotropy | 1 | 2015 | 77 | 0.030 |
Why?
| | Methylmercury Compounds | 1 | 2014 | 8 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2015 | 149 | 0.030 |
Why?
| | Troponin I | 1 | 2015 | 81 | 0.030 |
Why?
| | Point Mutation | 1 | 1995 | 237 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1862 | 0.030 |
Why?
| | Introns | 1 | 1995 | 253 | 0.030 |
Why?
| | Goals | 1 | 2016 | 178 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 344 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 391 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 303 | 0.030 |
Why?
| | Axons | 1 | 2015 | 198 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 398 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.030 |
Why?
| | HeLa Cells | 1 | 1995 | 639 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2013 | 30 | 0.020 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2013 | 27 | 0.020 |
Why?
| | Manganese Compounds | 1 | 2012 | 2 | 0.020 |
Why?
| | United States | 3 | 2021 | 15195 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 447 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2014 | 244 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2012 | 127 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2015 | 737 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2898 | 0.020 |
Why?
| | PAX6 Transcription Factor | 1 | 2012 | 21 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2015 | 837 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1968 | 0.020 |
Why?
| | Homeostasis | 2 | 2007 | 636 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2014 | 329 | 0.020 |
Why?
| | Age Factors | 1 | 1999 | 3278 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 1995 | 556 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2152 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2012 | 138 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2012 | 176 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1758 | 0.020 |
Why?
| | Young Adult | 2 | 2018 | 13646 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7035 | 0.020 |
Why?
| | Models, Molecular | 1 | 2015 | 1602 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 34487 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 632 | 0.020 |
Why?
| | Risk Factors | 2 | 2014 | 10430 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1815 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 2238 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2056 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5895 | 0.020 |
Why?
| | Nerve Degeneration | 1 | 2007 | 49 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6257 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3336 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2007 | 105 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 157 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1995 | 2003 | 0.020 |
Why?
| | Neocortex | 1 | 2007 | 44 | 0.020 |
Why?
| | Long-Term Potentiation | 1 | 2007 | 200 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2003 | 70 | 0.010 |
Why?
| | Gliosis | 1 | 2003 | 28 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11125 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 217 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 207 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6944 | 0.010 |
Why?
| | Hippocampus | 1 | 2007 | 939 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 16315 | 0.010 |
Why?
| | Synapses | 1 | 2003 | 428 | 0.010 |
Why?
| | Aged | 1 | 2016 | 24666 | 0.010 |
Why?
| | Awards and Prizes | 1 | 1996 | 72 | 0.010 |
Why?
| | Hematopoiesis | 1 | 1996 | 193 | 0.010 |
Why?
| | Societies, Medical | 1 | 1996 | 852 | 0.010 |
Why?
| | Biomarkers | 1 | 2002 | 4175 | 0.010 |
Why?
|
|
Ess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|